Advertisement
Screener

NEXGEL, INC. (NXGL) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.0 / 5 stars · 28/69 Roast Me

NEXGEL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

NEXGEL, INC. (NXGL) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 76.07% for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-17

  • NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-03-31 was 76.07%, a 2.74% decline year-over-year.
  • NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-03-31 was 78.21%, a 69.69% decline year-over-year.
  • NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 258.01%, a 0.14% increase year-over-year.
  • NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 257.64%.
  • NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 277.84%.
  • NEXGEL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2019 was 88.42%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month
2026-03-3176.07%
10-Q · filed 2026-05-14
2025-06-3078.21%
10-Q · filed 2026-08-17
2025-03-3178.21%
10-Q · filed 2026-05-14
2024-06-30258.01%
10-Q · filed 2025-08-12
2024-03-31258.01%
10-Q · filed 2025-05-13
2023-06-30257.64%
10-Q · filed 2023-08-14
2023-03-31257.64%
10-Q · filed 2023-05-15
2022-12-31277.84%
10-K · filed 2024-04-10
2020-06-30136.81%
10-Q · filed 2020-08-14
2020-03-31136.81%
10-Q · filed 2020-05-14
2019-12-3188.42%
10-K/A · filed 2020-04-03
2019-09-3088.42%
10-Q · filed 2020-01-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Tenon Medical, Inc. (TNON)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Profusa, Inc. (PFSA)United States$0.002B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B